PROVETOP

Biotinylated Human ALCAM/CD166 Protein (Primary Amine Labeling)

Catalog No: ALCAM-HB001

Species
Human
Expression System
HEK293
Tag
His
Activity
Activity verified

Product overview

Recombinant Biotinylated Human ALCAM/CD166 Protein (Primary Amine Labeling) is expressed in HEK293 cells with a His tag at the C-terminus. It contains amino acid residues Trp28-Ala526 (UniProt accession: Q13740-1).

Product Details

Molecular Aliases
CD166; ALCAM; MEMD; CD6L; KG-CAM
Protein Length
Trp28-Ala526
Expression System
HEK293
Theoretical Molecular Weight
The protein has a predicted MW of 57 kDa. Due to glycosylation, the protein migrates to 70-80 kDa based on Bis-Tris PAGE result.
Purity
> 95% as determined by Bis-Tris PAGE
Endotoxin
Less than 1 EU per ug by the LAL method.
Buffer / Formulation
Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
State
Lyophilized
Storage Conditions
-20 to -80°C for 12 months as supplied from date of receipt. -80°C for 3 months after reconstitution. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Reconstitution Advice
Dissolve the lyophilized protein in distilled water. Please refer to the Certificate of Analysis for detailed instructions.

Data Display

Bis-Tris PAGE
ALCAM-HB001 Bis-Tris-PAGE-white result

Biotinylated Human ALCAM (Primary Amine Labeling) on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

ELISA
ALCAM-HB001 ELISA result

Immobilized Anti-ALCAM Antibody, hFc Tag at 5μg/ml (100μl/well) on the plate. Dose response curve for Biotinylated Human ALCAM, His Tag with the EC50 of 2.62μg/ml determined by ELISA.

Background

Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) is a glycoprotein involved in homotypic and heterotypic cell adhesion. ALCAM can be proteolytically cleaved at the cell surface by metalloproteases, which generate shedding of its ectodomain. In various tumors, ALCAM is overexpressed and serves as a valuable prognostic marker of disease progression.

References

  1. Ferragut F, Vachetta VS, Troncoso MF, Rabinovich GA, Elola MT. ALCAM/CD166: A pleiotropic mediator of cell adhesion, stemness and cancer progression. Cytokine Growth Factor Rev. 2021 Oct;61:27-37. doi: 10.1016/j.cytogfr.2021.07.001. Epub 2021 Jul 9. PMID: 34272152.

Have questions about this product?

Our technical team can help with product selection, application questions and order support.

Contact Technical Support